BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 26269406)

  • 1. PLCG1 Gene Mutations in Cutaneous T-Cell Lymphomas Revisited.
    Tensen CP
    J Invest Dermatol; 2015 Sep; 135(9):2153-2154. PubMed ID: 26269406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PLCG1 mutations in cutaneous T-cell lymphomas.
    Vaqué JP; Gómez-López G; Monsálvez V; Varela I; Martínez N; Pérez C; Domínguez O; Graña O; Rodríguez-Peralto JL; Rodríguez-Pinilla SM; González-Vela C; Rubio-Camarillo M; Martín-Sánchez E; Pisano DG; Papadavid E; Papadaki T; Requena L; García-Marco JA; Méndez M; Provencio M; Hospital M; Suárez-Massa D; Postigo C; San Segundo D; López-Hoyos M; Ortiz-Romero PL; Piris MA; Sánchez-Beato M
    Blood; 2014 Mar; 123(13):2034-43. PubMed ID: 24497536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PLCG1 Gene Mutations Are Uncommon in Cutaneous T-Cell Lymphomas.
    Caumont C; Gros A; Boucher C; Mélard P; Prochazkova-Carlotti M; Laharanne E; Pham-Ledard A; Vergier B; Chevret E; Beylot-Barry M; Merlio JP; Cappellen D
    J Invest Dermatol; 2015 Sep; 135(9):2334-2337. PubMed ID: 25910029
    [No Abstract]   [Full Text] [Related]  

  • 4. Frequent and Persistent PLCG1 Mutations in Sézary Cells Directly Enhance PLCγ1 Activity and Stimulate NFκB, AP-1, and NFAT Signaling.
    Patel VM; Flanagan CE; Martins M; Jones CL; Butler RM; Woollard WJ; Bakr FS; Yoxall A; Begum N; Katan M; Whittaker SJ; Mitchell TJ
    J Invest Dermatol; 2020 Feb; 140(2):380-389.e4. PubMed ID: 31376383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetics of Cutaneous T Cell Lymphoma: From Bench to Bedside.
    Damsky WE; Choi J
    Curr Treat Options Oncol; 2016 Jul; 17(7):33. PubMed ID: 27262707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paucity of FOXP3+ cells in skin and peripheral blood distinguishes Sézary syndrome from other cutaneous T-cell lymphomas.
    Klemke CD; Fritzsching B; Franz B; Kleinmann EV; Oberle N; Poenitz N; Sykora J; Banham AH; Roncador G; Kuhn A; Goerdt S; Krammer PH; Suri-Payer E
    Leukemia; 2006 Jun; 20(6):1123-9. PubMed ID: 16557241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological insights into the pathogenesis of cutaneous T-cell lymphomas (CTCL).
    Whittaker S
    Semin Oncol; 2006 Feb; 33(1 Suppl 3):S3-6. PubMed ID: 16516668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mutational landscape of cutaneous T cell lymphoma and Sézary syndrome.
    da Silva Almeida AC; Abate F; Khiabanian H; Martinez-Escala E; Guitart J; Tensen CP; Vermeer MH; Rabadan R; Ferrando A; Palomero T
    Nat Genet; 2015 Dec; 47(12):1465-70. PubMed ID: 26551667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunophenotyping and gene rearrangement analysis provide additional criteria to differentiate between cutaneous T-cell lymphomas and pseudo-T-cell lymphomas.
    Bakels V; van Oostveen JW; van der Putte SC; Meijer CJ; Willemze R
    Am J Pathol; 1997 Jun; 150(6):1941-9. PubMed ID: 9176388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of T-follicular helper markers in sequential biopsies of progressive mycosis fungoides and other primary cutaneous T-cell lymphomas.
    Bosisio FM; Cerroni L
    Am J Dermatopathol; 2015 Feb; 37(2):115-21. PubMed ID: 25406852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide analysis of cutaneous T-cell lymphomas identifies three clinically relevant classes.
    Laharanne E; Oumouhou N; Bonnet F; Carlotti M; Gentil C; Chevret E; Jouary T; Longy M; Vergier B; Beylot-Barry M; Merlio JP
    J Invest Dermatol; 2010 Jun; 130(6):1707-18. PubMed ID: 20130593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
    Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
    J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant phospholipase C gamma 1 activity promotes CTCL growth.
    Cancer Discov; 2014 Apr; 4(4):OF13. PubMed ID: 24706664
    [No Abstract]   [Full Text] [Related]  

  • 14. Primary cutaneous T-cell lymphomas show a deletion or translocation affecting NAV3, the human UNC-53 homologue.
    Karenko L; Hahtola S; Päivinen S; Karhu R; Syrjä S; Kähkönen M; Nedoszytko B; Kytölä S; Zhou Y; Blazevic V; Pesonen M; Nevala H; Nupponen N; Sihto H; Krebs I; Poustka A; Roszkiewicz J; Saksela K; Peterson P; Visakorpi T; Ranki A
    Cancer Res; 2005 Sep; 65(18):8101-10. PubMed ID: 16166283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High expression of Dicer reveals a negative prognostic influence in certain subtypes of primary cutaneous T cell lymphomas.
    Valencak J; Schmid K; Trautinger F; Wallnöfer W; Muellauer L; Soleiman A; Knobler R; Haitel A; Pehamberger H; Raderer M
    J Dermatol Sci; 2011 Dec; 64(3):185-90. PubMed ID: 21937200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular advances in cutaneous T-cell lymphoma.
    Bastidas Torres AN; Najidh S; Tensen CP; Vermeer MH
    Semin Cutan Med Surg; 2018 Mar; 37(1):81-86. PubMed ID: 29719024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-cell receptor-gamma gene analysis in evolving to advancing cutaneous T-cell lymphoma.
    Foo CC; Tang MB; Chong TK; Sun YJ; Tan SH
    Australas J Dermatol; 2007 Aug; 48(3):156-60. PubMed ID: 17680965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrent presence of the PLCG1 S345F mutation in nodal peripheral T-cell lymphomas.
    Manso R; Rodríguez-Pinilla SM; González-Rincón J; Gómez S; Monsalvo S; Llamas P; Rojo F; Pérez-Callejo D; Cereceda L; Limeres MA; Maeso C; Ferrando L; Pérez-Seoane C; Rodríguez G; Arrinda JM; García-Bragado F; Franco R; Rodriguez-Peralto JL; González-Carreró J; Martín-Dávila F; Piris MA; Sánchez-Beato M
    Haematologica; 2015 Jan; 100(1):e25-7. PubMed ID: 25304611
    [No Abstract]   [Full Text] [Related]  

  • 19. T-cell receptor gamma gene rearrangement in cutaneous T-cell lymphoma: comparative study of polymerase chain reaction with denaturing gradient gel electrophoresis and GeneScan analysis.
    Goeldel AL; Cornillet-Lefebvre P; Durlach A; Birembaut P; Bernard P; Nguyen P; Grange F
    Br J Dermatol; 2010 Apr; 162(4):822-9. PubMed ID: 19906072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of c-myb in leukaemic and non-leukaemic variants of cutaneous T-cell lymphoma.
    Poenitz N; Simon-Ackermann J; Gratchev A; Qadoumi M; Klemke CD; Stadler R; Kremer A; Radenhausen M; Henke U; Assaf C; Utikal J; Goerdt S; Dippel E
    Dermatology; 2005; 211(2):84-92. PubMed ID: 16088151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.